Ticker Launch
Sign inTry it free

IPO · DNAY

Telesis Bio Inc.

Formerly Codex DNA, Inc.

Telesis Bio Inc. (DNAY) priced its initial public offering on Jun 21, 2021 at $16.00 per share, within its $14.00–$16.00 range, raising $106.7M, and listed on Nasdaq Global Select. At the IPO price its market capitalization was about $451.7M. Jefferies was lead-left underwriter, joined by TD Cowen and KeyBanc. Wilson Sonsini advised the company and Covington & Burling advised the underwriters.

Telesis Bio Inc. is a synthetic biology company that enables researchers to build high-quality synthetic DNA and mRNA. Its BioXp system is an automated benchtop workstation that handles the multi-step process of building DNA and mRNA.

Status
IPO
Ticker
DNAY
Exchange
Nasdaq Global Select
Priced
Jun 21, 2021
IPO price
$16.00
Price range
$14.00–$16.00
Raised
$106.7M
Market cap at IPO price
$451.7M
First filed
May 28, 2021
Underwriters
Jefferies, TD Cowen and KeyBanc
Company counsel
Wilson Sonsini
Underwriters' counsel
Covington & Burling
Sector
Industrials & materials
Country / state
CA

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.

More on this listing for subscribers

Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.

Try it free for 7 daysOpen in Ticker Launch

Then $99/month or $999/year. Cancel anytime.

Filings

Other Industrials & materials IPOs in 2021